FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to pharmaceutical formulation for local dermal application to induce cytokine biosynthesis, containing immunomodulator 2-methyl-1-(2-methylpropyl)- 1H-imidazo[4,5-c][1,5]naphtirydine-4-amin, fatty acid, hydrophobic aprotonic component, emulsifier, hydrophilic component and water.
EFFECT: high effective induction of cytokine biosynthesis.
7 cl, 18 tbl, 140 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYSTEMS AND METHODS OF MUCOSA SURFACE TREATMENT | 2001 |
|
RU2349321C2 |
| SUBSTITUTED IMIDAZOPYRIDINES | 2001 |
|
RU2294934C2 |
| METHOD FOR TREATMENT OF STATES CAUSED BY p38 KINASES AND PYRROLOTRIAZINE COMPOUNDS USED AS KINASE INHIBITORS | 2001 |
|
RU2316556C2 |
| UREA-SUBSTITUTED IMIDAZOQUINOLINE ETHERS | 2001 |
|
RU2302418C2 |
| 2-S-BENZYLSUBSTITUTED PYRIMIDINES AS CRTH2 ANTAGONISTS | 2008 |
|
RU2491279C2 |
| DERIVATIVES OF 2-AMINO-4H-3,1-BENZOXAZINE-4-ONE FOR PROPHYLAXIS OR TREATMENT OF OBESITY OR ACCOMPANYING DISORDER | 2000 |
|
RU2244711C2 |
| HETEROCYCLIC COMPOUNDS HAVING 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITING ACTIVITY | 2006 |
|
RU2443689C2 |
| DERIVATIVES OF 2-OXY-4H-3,1-BENZOXAZINE-2-ONE FOR PROPHYLAXIS AND/OR TREATMENT OF OBESITY OR ACCOMPANYING DISORDER | 2000 |
|
RU2245331C2 |
| PYRAZOLOPYRIDINES AND ANALOGUES THEREOF | 2004 |
|
RU2426734C2 |
| DERIVATIVES OF 1,10b-DIHYDRO-2-(AMINOCARBONYLPHENYL)-5H-PYRAZOLO[1,5-c][1,3]BENZOXASIN-5-YL)PHENYLMETHYLMETHANON AS INHIBITORS OF HIV VIRUS REPLICATION | 2005 |
|
RU2382789C2 |
